Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last ¥3,810 JPY
Change Today -25.00 / -0.65%
Volume 541.3K
4519 On Other Exchanges
Symbol
Exchange
Tokyo
OTC US
Frankfurt
As of 2:00 AM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Tatsuro Kosaka

President, Chief Operating Officer and Representative Director, Chugai Pharmaceutical Co. Ltd.
AgeTotal Calculated CompensationThis person is connected to 22 board members in 1 different organizations across 2 different industries.

See Board Relationships
--¥104,000,000
As of Fiscal Year 2013

Background*

Mr. Tatsuro Kosaka has been the President and Chief Operating Officer at Chugai Pharmaceutical Co. Ltd. since February 2012. Mr. Kosaka served as Executive Vice President of Business Development at Chugai Pharmaceutical Co. Ltd. until February 2012. Mr. Kosaka served as Executive Vice President and Head of Lifecycle Management & Marketing Unit of Overseas Development of Chugai Pharmaceutical Co. Ltd. Mr. Kosaka served as Head of Lifecycle Management & Marketing Unit ...

Read Full Background

Corporate Headquarters*

1-1 Nihonbashi-Muromachi 2-Chome
Tokyo, -- 103-8324

Japan

Phone: 81 3 3281 6611
Fax: 81 3 3281 6607

Board Members Memberships*

2010-Present
President, Chief Operating Officer and Representative Director

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

Salary¥51,000,000
Bonus¥23,000,000
Total Annual Compensation¥74,000,000

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation¥74,000,000
Total Short Term Compensation¥74,000,000
Total Calculated Compensation¥104,000,000
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4519:JP ¥3,810.00 JPY -25.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Erez Vigodman Chief Executive Officer, President, Director and Member of Finance & Invesment Committee
Teva Pharmaceutical Industries Limited
--
Karl-Ludwig Kley Chairman of Executive Board and Chief Executive Officer
Merck KGaA
€6.6M
F. Michael Ball Chief Executive Officer, Director and Member of Science & Technology Committee
Hospira Inc.
$1.1M
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.6M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHUGAI PHARMACEUTICAL CO LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.